Those researchers requesting access to the AMYPAD PNHS should accept the responsible use of the data under the terms described in this document. Briefly, the following points are mentioned: Amsterdam UMC – location VUMC remains as the data controller of the dataset, while the user becomes a data processor and, therefore, will process the data only on behalf of the AMYPAD Consortium. There will be no attempt to establish or retrieve the identity of the study participants. The data will not be redistributed with others unless they have independently applied and been granted access. Secondary and derived data will be shared only at the group level. The AMYPAD PNHS Publication Policy should be used when publicly presenting any results or algorithms

AMYPAD PNHS is registered at www.clinicaltrialsregister.eu with the EudraCT Number: 2018-002277-22. The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. This Joint Undertaking received support from the European Union's Horizon 2020 research and innovation programme and EFPIA.